Alcon AG | ALC - Ebit





Ebit Veränderung Datum
AstraZeneca USD 3.16B 3.95B 2026-06
Bayer EUR 755M 2.77B 2026-06
Essilor EUR 2.3B 919M 2026-06
Fresenius EUR 719M 118M 2026-06
Fresenius Medical Care EUR 480.55M 212.55M 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
GRIFOLS EUR 428M 179M 2026-06
Lonza CHF 673M 54M 2025-06
Merck EUR 1.1B 51M 2026-06
Novartis USD 4.73B 549M 2026-06
Philips EUR 641M 339M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 1.12B 811M 2026-06
Smith & Nephew USD 505M 65M 2026-06
Sonova Holding CHF 296.8M 156.9M 2025-12
UCB EUR 1.29B 571M 2025-12